Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period [Phase 2, Phase 3]
12-week study of Pramipexole Extended Release in Parkinson disease followed by a 52-week long-term treatment period; the Phase 2/3 trial com…
-
FDA approval · 2011-02-03FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories Inc.'s supplemental application for Carbidopa and Levodopa.
-
FDA approval · 2011-02-03FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for a generic Carbidopa and Levodopa product from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2011-02-01FDA Approved: SINEMET — Supplemental Application (Organon LLC)
FDA granted supplemental approval for SINEMET (carbidopa and levodopa) by Organon LLC, updating the labeling as part of the supplemental app…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: 18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD [Phase 3]
An 18-month Phase 3 study evaluating safinamide as add-on therapy for mid-to-late stage Parkinson's disease has completed, examining long-te…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus [NA]
This clinical trial update examines facial emotion recognition and categorization of emotional words in Parkinson's disease and assesses the…
-
CLINICAL_TRIALS research · 2011-01-19Clinical Trial Update: Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease [NA]
This is a clinical trial update examining glucose tolerance in patients with idiopathic Parkinson's disease. The current status of the trial…
-
FDA approval · 2011-01-14FDA Approved: DATSCAN — Original Application (Medi-Physics Inc. dba GE Healthcare.)
FDA approved the original application for DATSCAN (ioflupane I-123), a radiopharmaceutical for brain imaging to aid in differentiating Parki…
-
CLINICAL_TRIALS research · 2011-01-14Clinical Trial Update: Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient
This document describes a prospective clinical trial comparing outcomes of subthalamic nucleus deep brain stimulation in early-treated versu…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off [Phase 4]
Phase 4 trial comparing Carbidopa/Levodopa/Entacapone vs immediate-release Carbidopa/Levodopa in Parkinson's disease patients with non-motor…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease [Phase 3]
An open-label extension trial evaluated the long-term safety of extended-release ropinirole (Ropinirole XL) in Parkinson's disease, with res…
-
CLINICAL_TRIALS research · 2010-12-20Clinical Trial Update: Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients
The clinical trial is developing a fall prevention and fall detection system for ambulatory rehabilitation in Parkinson's disease, but the s…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease [Phase 4]
Phase 4 trial evaluating desmopressin for nocturnal micturition frequency in Parkinson disease was terminated.
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study [Phase 4]
This document reports the completion and posting of results for a long-term Phase 4 trial of REQUIP (ropinirole hydrochloride IR) in Parkins…
-
CLINICAL_TRIALS research · 2010-12-14Clinical Trial Update: Biofeedback to Ameliorate Freezing of Gait [NA]
A clinical trial update exploring biofeedback as a potential method to reduce freezing of gait in Parkinson's disease; current status is unk…
-
FDA approval · 2010-11-30FDA Approved: SELEGILINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA issued supplemental approval for Selegiline hydrochloride (Apotex Corp.) under an ANDA. The action confirms approval of a supplemental a…
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Reduction of Falls in the Elderly - Parkinson's Disease [Phase 3]
Phase 3 clinical trial evaluating interventions to reduce falls in elderly patients with Parkinson's disease has completed. The summary note…
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
Clinical trial update reporting results from a long-term use survey of pramipexole in Parkinson's disease patients.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa
A completed Boehringer Ingelheim-sponsored clinical trial survey evaluating Parkinson disease patients not using L-Dopa; results were posted…
-
CLINICAL_TRIALS research · 2010-11-23Clinical Trial Update: Sensory Attention Focused Exercise in Parkinson's Disease [NA]
An update on a clinical trial studying sensory attention focused exercise as a treatment for Parkinson's disease.
-
CLINICAL_TRIALS research · 2010-11-22Clinical Trial Update: Visual Selective Attention in Parkinson's Disease
This clinical trial sponsored by University Hospital Grenoble investigated visual selective attention in individuals with Parkinson's diseas…
-
FDA approval · 2010-11-17FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved the generic Trihexyphenidyl hydrochloride under an Original Application by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Enteric Nervous System in Parkinson's Disease [NA]
A completed clinical trial at Nantes University Hospital investigated the enteric nervous system in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2010-11-11Clinical Trial Update: Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease [Phase 4]
Phase 4 trial evaluating Ramelteon (Rozerem) for sleep disturbances in Parkinson's disease has been terminated.
-
CLINICAL_TRIALS research · 2010-11-11Clinical Trial Update: Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease [NA]
Clinical trial update describing a study on the effects of vitamin B6, vitamin B12, folic acid, and exercise in Parkinson's disease, sponsor…